Agenus AGEN
NASDAQ AGEN
$8.24 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:59 PM EDT

Agenus (AGEN) Other Accumulated Expenses (2010 - 2026)

Agenus (AGEN) posted quarterly Other Accumulated Expenses of $514000.0 for Q1 2026, down 89.76% year-over-year from $5.0 million in Q1 2025, and down 2.84% quarter-over-quarter from $529000.0 in Q4 2025.

Analysis

Agenus (AGEN) Other Accumulated Expenses (2010 - 2026) Analysis & Trends

Agenus' Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $514000.0 for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses fell 89.76% year-over-year to $514000.0; the TTM figure through Mar 2026 stood at $514000.0 (down 89.76% YoY), while the FY2025 annual figure was $529000.0, down 93.23% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $514000.0, down from $529000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $14.0 million in Q1 2024, with the low at $514000.0 in Q1 2026.
  • The 5-year median for Other Accumulated Expenses is $7.3 million (2024), against an average of $7.7 million.
  • The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses soared 260.16% in 2023, then sank 93.23% in 2025.
  • Agenus' Other Accumulated Expenses stood at $11.5 million in 2022, then advanced by 21.45% to $13.9 million in 2023, then plunged by 43.82% to $7.8 million in 2024, then tumbled by 93.23% to $529000.0 in 2025, then fell by 2.84% to $514000.0 in 2026.
  • Business Quant data shows AGEN's Other Accumulated Expenses at $514000.0 in Q1 2026, $529000.0 in Q4 2025, and $7.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Agenus 342.07 Mn 342.07 Mn 34.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.43 Mn
Mar 31, 2026 5.61 Mn
Dec 31, 2025 9.11 Mn
Sep 30, 2025 7.36 Mn
Jun 30, 2025 7.32 Mn
Mar 31, 2025 6.88 Mn
Dec 31, 2024 7.82 Mn
Sep 30, 2024 12.57 Mn
Jun 30, 2024 16.34 Mn
Mar 31, 2024 14.03 Mn
Dec 31, 2023 13.92 Mn
Sep 30, 2023 13.42 Mn
Jun 30, 2023 13.27 Mn
Mar 31, 2023 12.94 Mn
Dec 31, 2022 11.46 Mn
Sep 30, 2022 4.97 Mn
Jun 30, 2022 4.98 Mn
Mar 31, 2022 6.36 Mn
Dec 31, 2021 7.08 Mn
Sep 30, 2021 6.78 Mn